Physicians' perceptions about managed care restrictions on antibiotic prescribing

M Hasty1, J Schrager, K Wrenn

  • 1Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, TN 37232-4700, USA.

Insights

Emergency medicine physicians often overestimate managed care restrictions on antibiotic prescribing. Objective data revealed actual formulary impacts were significantly lower than perceived by physicians.

Area of Science:

  • Health Services Research
  • Medical Economics
  • Clinical Practice

Background:

  • Managed care organizations (MCOs) implement drug formularies to control costs.
  • Physician perceptions of formulary restrictions may influence prescribing behavior.
  • Understanding the gap between perceived and actual restrictions is crucial for effective healthcare management.

Purpose of the Study:

  • To compare emergency medicine physicians' perceptions of managed care restrictions on antibiotic prescribing with objective data.
  • To quantify the discrepancy between perceived and actual formulary impacts on antibiotic selection.

Main Methods:

  • A survey assessed general perceptions of managed care restrictions among 17 emergency medicine physicians.
  • Objective prescribing data was collected by reviewing recent patient cases for specific antibiotic choices.
  • Statistical analysis (p-value) was used to compare perceived versus actual restriction frequencies.

Main Results:

  • Physicians reported prescribing non-first-choice antibiotics due to managed care restrictions 32% of the time.
  • Objective review showed actual non-first-choice antibiotic prescribing occurred only 6% of the time (p <.0001).
  • A significant overestimation of formulary restrictions by physicians was identified.

Conclusions:

  • Emergency medicine physicians in this managed care setting significantly overestimated the impact of formularies on their antibiotic prescribing.
  • Perceived restrictions by managed care significantly differ from objective measures.
  • Further research is needed to understand and address this perception bias in clinical practice.

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...